Delhi-based medical device maker Poly Medicure expects its revenue to grow by about 22–25% from the first half to the second half of the year.

Speaking to CNBC-TV18, Managing Director Himanshu Baid said, “We see the traction coming back in the international market, while the domestic business continues to grow at a steady pace.”

The company is confident of achieving a 15-16% revenue growth for the fiscal year 2026 (FY26), despite facing significant headwinds in its export markets. The company had previously revised its guidance down from 20% on account of a drag in international business.

The first half (H1) of the year saw the domestic business grow by a robust 18-19%, while exports remained flat. Baid explained that the export challenges, particularly in Europe, were due to aggressiv

See Full Page